Last reviewed · How we verify

NCT03871920

Psychometric Evaluation of the Short Patient Evaluation Questionnaire

Status unknown Last updated 12 March 2019
What this trial tests

trial testing physical therapy treatment in Patient Reported Outcomes in 250 participants. Status unknown.

Timeline
1 June 2019
Primary endpoint
1 June 2019
1 October 2019

Quick facts

Lead sponsorNanco van der Maas
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment250
Start date1 June 2019
Primary completion1 June 2019
Estimated completion1 October 2019

Drugs / interventions tested

Conditions studied

Sponsor

Nanco van der Maas

Who can join

18 and older, any sex, with Patient Reported Outcomes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It is important for physiotherapy in general and for the individual physio-therapist to demonstrate the result of the interventions in physiotherapy. The new short (4 items) generic questionnaire Short Patient Evaluation Questionnaire SPEQ was especially developed for use in private practices to answer the main questions for evaluation of treatment. This research project aims at evaluating the reliability, validity and responsiveness of the SPEQ and at providing an estimate for Minimal Important Difference MID that may be used as threshold for clinical relevant changes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of physical therapy treatment

Trials testing the same drug.

Other Nanco van der Maas trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03871920.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing